欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/0872/004
药品名称	FOSTER NEXThaler 200 Mikrogramm/6 Mikrogramm pro Inhalation Pulver zur Inhalation
活性成分	beclometasone 0.2 mg formoterol 0.01 mg
剂型	Inhalation powder
上市许可持有人	Chiesi GmbH Gasstr. 6 22761 Hamburg Germany
参考成员国 - 产品名称	Germany (DE) Foster NEXThaler 200/6 Pulver zur Inhalation
互认成员国 - 产品名称	Italy (IT)
许可日期	2015/07/15
最近更新日期	2022/12/20
药物ATC编码	R03AK08 formoterol and beclometasone
申请类型	TypeLevel1：Line Extension TypeLevel2：Multiple (Copy) Application TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final PL \| DE_871-874_003_ SmPC_BDP+FF 200+6 HFA_tracked_20200527_renewalDate of last change:2020/05/27 Final PL \| DE_871-874_003_PIL BDP+FF 200+6 HFA_120D_tracked_20200527_renewalDate of last change:2020/05/27 Final SPC \| DE_871-874_003_ SmPC_BDP+FF 200+6 HFA_tracked_20200527_renewalDate of last change:2020/05/27 Final SPC \| DE_0871-0874 _004_ SmPC _hv_20200527_renewalDate of last change:2020/05/27 Final PL \| DE_871-874_003_PIL_BDP+FF 200+6 HFA 180D_tracked_20200527_renewalDate of last change:2020/05/27 PAR \| PAREN-DE 0871-0874_3-4_Kantos FosterDate of last change:2017/08/03 Final Product Information \| common-final-pl-0872-V046Date of last change:2017/06/07 Final Product Information \| common-final-smpc-0872-V046Date of last change:2017/06/07
市场状态	Positive